Physician profile
Ri Cha
NPI 1164502878
$3,409.15
in general payments reported to CMS, 2019-2025
16 companies · $328 in 2025
The $328 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $830 · 2020: $294 · 2021: $190 · 2022: $588 · 2023: $723 · 2024: $456 · 2025: $328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,506.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,506.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $860.94 | 2019-2023 | Xarelto |
| Atricure, INC. | $491.25 | 2022-2024 | |
| Philips North America LLC | $473.67 | 2022-2025 | (5044) Mcot, Extended Holter, Mcot |
| Pfizer INC. | $335.55 | 2019-2025 | |
| E.R. Squibb & Sons, L.L.C. | $300.60 | 2022-2025 | Eliquis, Camzyos |
| Amgen INC. | $265.25 | 2019-2023 | Repatha |
| Boehringer Ingelheim Pharmaceuticals, INC. | $237.10 | 2021-2023 | Jardiance |
| Alnylam Pharmaceuticals INC. | $121.55 | 2024 | Amvuttra |
| Novartis Pharmaceuticals Corporation | $120.86 | 2019-2023 | |
| Chiesi USA, INC. | $59.50 | 2022-2023 | Cleviprex |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $48.21 | 2019-2020 | |
| Kestra Medical Technology Services, INC. | $30.56 | 2022 | |
| Cvrx, INC. | $20.96 | 2025 | Barostim Neo System |
| Kiniksa Pharmaceuticals, Ltd. | $15.00 | 2023 | Arcalyst |
| Sanofi-Aventis U.S. LLC | $14.18 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $13.97 | 2024 | Bodyguardian |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ri Cha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.